Skip to main content
. 2016 Apr 26;7(23):34907–34917. doi: 10.18632/oncotarget.8995

Table 1. Significantly altered serum proteins during neoadjuvant therapy.

Post-NACT Post-CRT Evaluation
ADIPOQ 1.15 ACVR1 1.10 IGFBP3 1.21 ADIPOQ 1.10 GRN 1.12
ANG 1.21 ADIPOQ 1.10 IGFBP7 1.12 ANG 1.11 IGF2 1.21
IGFBP2 1.15 ANG 1.21 IL1RAPL2 1.10 ANGPT2 1.16 IGFBP7 1.15
IL6ST 1.12 BMPR1A 1.11 IL27 1.12 BDNF 1.11 IL1RAPL2 1.11
NCAM1 1.12 CCL1 1.11 IL6ST 1.17 BMPR1A 1.18 IL22 1.12
SAA1 1.15 CCL11 1.12 LBP 1.16 CCL11 1.14 IL6ST 1.12
TNFRSF11B 1.34 CCL22 1.13 LEPR 1.11 CCR6 1.14 LIFR 1.12
CCR6 1.10 PLAU 1.12 CD14 1.13 MMP2 1.10
CD14 1.14 RARRES2 1.12 CSF1 1.19 NGFB 1.12
CSF1 1.22 RELT 1.11 CTF1 1.12 NTF4 1.13
EGFR 1.11 SAA1 1.27 CXCR1 1.19 RARRES2 1.23
ERBB2 1.20 SIGLEC5 1.14 CXCR5 1.11 SIGLEC9 1.12
FLT3LG 1.11 SIGLEC9 1.13 CXCR6 1.12 SLC2A2 1.19
GCG 1.13 SLC2A2 1.13 ERBB2 1.11 THBS4 1.12
GRN 1.16 TGFBR1 1.11 ERBB4 1.11 TNFRSF11B 1.16
IGF2 1.18 THBS4 1.10 FLT3LG 1.12
IGFBP2 1.15 TNFRSF11B 1.65
LCN2 0.65 CHRDL2 0.88 PDGFA 0.86 CHRDL2 0.86 PDGFA 0.88
LTBP1 0.87 CXCL2 0.88 PDGFB 0.89 FGF13 0.84 S100A12 0.84
MMP9 0.63 FGF13 0.83 PF4 0.85 LCN2 0.84 TMEFF2 0.89
LCN2 0.73 PPBP 0.83 MMP9 0.74
LTBP1 0.80 S100A12 0.85
MMP9 0.68 THBS1 0.84

Array values of the proteins were transformed to natural logarithms. The fold-change increase or decrease following induction neoadjuvant chemotherapy (post-NACT) and sequential chemoradiotherapy (post-CRT) and at evaluation of the neoadjuvant treatment, relative to baseline, is indicated on the right of each protein. Proteins are listed by their gene names (TNFRSF11B, in italic, corresponds to osteoprotegerin).